Background: Over one-fifth of the global adult population is affected by elevated blood pressure, while cardiovascular diseases contribute to around 17 million deaths annually, representing nearly one-third of all deaths worldwide. Ayurvedic treatments play a significant role in effectively alleviating the signs and symptoms of such diseases. Masyadi Kashaya, with its specific ingredients, acts on the root cause of the condition and helps in its management. Aims & Objective - This study aims to evaluate the therapeutic efficacy of Mansyadi Kwath in the management of Uccha Raktachapa w.s.r. to Hypertension (HTN).

Material and Methods: Randomized open clinical trial of Masyadi Kwatha was done on population size of 80, for the period of one month and assesd befor and after the treatment.  Result and Discussion: Response of the intervention has been defined in lieu of improvement in the Sign & Symptoms along with subjective and objective parameters. The trial drug Mansyadi Kwath was well tolerated having no patients force to discontinue out of drug intolerance. The Clinical assessment of results shows that_, Maximum number of patients 56 (70%) got moderate improvement and only 24 (30%) of patients got mild improvement after 30 days of treatment.